全文获取类型
收费全文 | 8188篇 |
免费 | 770篇 |
国内免费 | 627篇 |
专业分类
耳鼻咽喉 | 78篇 |
儿科学 | 68篇 |
妇产科学 | 60篇 |
基础医学 | 902篇 |
口腔科学 | 112篇 |
临床医学 | 1037篇 |
内科学 | 999篇 |
皮肤病学 | 110篇 |
神经病学 | 445篇 |
特种医学 | 359篇 |
外国民族医学 | 8篇 |
外科学 | 906篇 |
综合类 | 1552篇 |
现状与发展 | 5篇 |
预防医学 | 592篇 |
眼科学 | 310篇 |
药学 | 863篇 |
1篇 | |
中国医学 | 515篇 |
肿瘤学 | 663篇 |
出版年
2024年 | 22篇 |
2023年 | 108篇 |
2022年 | 274篇 |
2021年 | 374篇 |
2020年 | 268篇 |
2019年 | 242篇 |
2018年 | 244篇 |
2017年 | 234篇 |
2016年 | 243篇 |
2015年 | 364篇 |
2014年 | 463篇 |
2013年 | 424篇 |
2012年 | 656篇 |
2011年 | 731篇 |
2010年 | 490篇 |
2009年 | 423篇 |
2008年 | 466篇 |
2007年 | 514篇 |
2006年 | 404篇 |
2005年 | 417篇 |
2004年 | 301篇 |
2003年 | 285篇 |
2002年 | 238篇 |
2001年 | 222篇 |
2000年 | 226篇 |
1999年 | 207篇 |
1998年 | 89篇 |
1997年 | 101篇 |
1996年 | 65篇 |
1995年 | 55篇 |
1994年 | 59篇 |
1993年 | 27篇 |
1992年 | 47篇 |
1991年 | 35篇 |
1990年 | 23篇 |
1989年 | 38篇 |
1988年 | 27篇 |
1987年 | 26篇 |
1986年 | 22篇 |
1985年 | 20篇 |
1984年 | 10篇 |
1983年 | 6篇 |
1982年 | 6篇 |
1975年 | 6篇 |
1974年 | 7篇 |
1973年 | 7篇 |
1972年 | 11篇 |
1971年 | 7篇 |
1970年 | 9篇 |
1968年 | 5篇 |
排序方式: 共有9585条查询结果,搜索用时 31 毫秒
1.
目的 建立蒙药绿松石的质量标准。方法 收集不同产地绿松石,共10批。观察绿松石样品和粉末的性状并进行理化鉴别;按2020年版《中国药典》(四部)通则方法测定绿松石样品中水分、浸出物含量;采用原子吸收光谱法测定绿松石样品铜元素含量。结果 绿松石为不规则、周围带有黑石的块状物,表面蓝绿色,体重,质硬脆,难砸碎,断面呈贝壳状,蜡样光泽,粉末呈灰绿色,无臭,味淡;理化鉴别结果显示,呈铜盐反应;10批次样品中水分含量为0.41%-3.94%(SD=1.37%),浸出物含量为0.21%-0.81%(SD=0.21%),铜元素含量为3.03%-4.63%(SD=0.63%)。结论 初步拟定绿松石中水分含量不得超多5.0%、浸出物含量不得低于0.10%,铜元素含量应为2.60%-4.84%,制定的标准可用于蒙药材绿松石的质量控制。 相似文献
2.
目的 系统评价中药治疗哮喘-慢阻肺(ACO)的疗效与安全性。方法 全面检索PubMed、Cochrane Library、Web of Science、中国知网、万方、维普、中国医学文献数据库,纳入有关中医药治疗ACO的随机对照试验(RCT),运用Cochrane手册对纳入研究的方法学质量进行评估,采用Review Manager 5.3进行Meta分析。结果 共纳入32项RCT,包括2688例ACO患者,其中试验组1361例,对照组1327例。Meta分析结果显示,中医药可以显著改善ACO患者的中医证候疗效[RR=1.19,95% CI(1.13,1.25),P<0.00001]、CAT评分[MD=-3.62,95% CI(-4.37,-2.87),P<0.00001]、ACT评分[MD=3.42,95% CI(2.23,4.62),P<0.00001],、中医证候总积分[MD=-3.61,95% CI(-4.83,-2.39),P<0.00001]、FEV1[MD=0.59,95% CI(0.08,1.10),P=0.02]、FEV1%[MD=8.61,95% CI(5.20,12.1),P<0.00001]、FEV1/FVC[MD=6.52,95% CI(4.24,8.80),P<0.00001]、6 min步行实验[MD=41.18,95% CI(22.15,60.21),P<0.0001]、急性发作次数[MD=-2.46,95% CI(-3.62,-1.13),P<0.0001]。所有研究均未报道严重不良反应。结论 中药治疗ACO,可以显著提高临床疗效,改善患者的肺功能且具有较好安全性,但是需要更高质量、多样本、多中心的随机对照试验进一步确认。 相似文献
3.
Esin Benli Küçük Ercan Kaydok Kürsad Ramazan Zor Gamze Yıldırım Biçer 《Topics in stroke rehabilitation》2020,27(8):630-635
ABSTRACT Objective: Dry eye is reported to be associated with several neurological diseases. The aim of this study is to evaluate the patients with hemiplegia after stroke for dry eye and compare their results with a control group. Materials and methods: Forty-five patients with hemiplegia and 45 individuals as the control group were included in the study. Tear function tests (Schirmer and tear breakup time) and a dry eye questionnaire for dry eye symptoms (ocular surface disease index) were performed and the results of the two groups were compared. Results: Schirmer test results were significantly lower in the post-stroke hemiplegia group compared to the control group (11.3 ± 8.2 mm and 20.6 ± 11.6 mm, respectively, p < .001). Tear breakup time results were significantly lower in the post-stroke hemiplegia group compared to the control group (7.9 ± 3.1 s and 12.1 ± 4.3 s, respectively, p < .001). Ocular surface disease index scores were not significantly different between hemiplegia and control groups (21.6 ± 20.0 and 19.8 ± 13.9, respectively, p = .635). Schirmer scores lower than 10 mm (60% and 30%, p < .001) and tear breakup time results lower than 10 s (65.6% and 28.9%, p < .001) were also higher in the hemiplegia group compared to control group. Conclusion: We found lower Schirmer test and tear breakup time results and similar OSDI scores in hemiplegia patients compared to controls. Hemiplegia patients may have dry eye without typical symptoms. This should be taken into consideration in the follow-up and rehabilitation of post-stroke hemiplegia patients. 相似文献
4.
Parallel enzyme‐linked immunosorbent assay screening for human immunodeficiency virus among blood donors in five Chinese blood centres: a retrospective analysis
下载免费PDF全文
![点击此处可从《Transfusion medicine (Oxford, England)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
5.
The objective of the present study was to evaluate the clinical, radiological, and functional outcomes of a subscapularis transthoracic surgical approach and a posterolateral surgical approach with debridement, bone graft fusion, and internal fixation for the treatment of upper thoracic tuberculosis.There is currently debate over the best surgical approach for the treatment of upper thoracic tuberculosis. Traditionally, the subscapularis transthoracic approach has been preferred; however, the posterolateral approach has gained popularity in the past few years.A prospective, consecutive cohort of 43 upper thoracic tuberculosis patients with a mean age of 39 years (range: 20–52 years) was followed up for a minimum of 12 months (range: 12–60 months). Patients were randomly divided into 2 groups. Group A (n = 21) was treated by the subscapularis transthoracic approach and group B (n = 22) was treated by the posterolateral approach. All cases were evaluated for clinical, radiological, and functional outcomes. Intraoperative blood loss, operative duration, intraoperative and postoperative complications, hospital stay, the cure rate, fusion time, and the Frankel scale were used for clinical and functional evaluation, whereas the kyphosis angle was used for radiological evaluation.Grafted bones were fused by 10 months in all cases. There was no statistically significant difference between groups before surgery in terms of gender, age, segmental tuberculosis, erythrocyte sedimentation rate (ESR), Frankel scale, or Cobb''s angle (P > 0.05). The average operative duration for Group B was lower than that of Group A. There were no significant differences in intraoperative blood loss, intraoperative and postoperative complications, hospital stay, grafted bone fusion time, or cure rate between groups (P > 0.05). The Cobb''s angle correction rate for group B (68.5%) was significantly better than that of group A (30.9%). The neurological score showed significant postoperative improvement in both groups, with no significant difference between the groups.The subscapularis transthoracic approach and the posterolateral approach with debridement, bone graft fusion, and internal fixation are both sufficient and satisfactory for the surgical treatment of upper thoracic tuberculosis. However, the posterolateral approach is superior to the subscapularis transthoracic approach in terms of surgical trauma, operative time, and kyphosis correction. 相似文献
6.
氯吡格雷防治动脉粥样硬化缺血性疾病的研究进展 总被引:12,自引:0,他引:12
氯吡格雷防治动脉粥样硬化斑块破裂后血栓形成尤其是冠状动脉疾病及其经皮冠脉介入性治疗有了充足的临床试验证据,对于粥样斑块的形成和发展的相关依据正在进行,现就氯吡格雷全面预防和治疗动脉粥样硬化缺血性疾病的研究进展作一综述。 相似文献
7.
8.
中风毒邪论是一种与传统中医中风病理有所不同的理论 ,在中风毒邪论指导下形成解毒通络方是较为理想的神经保护剂 ,可解决目前神经保护治疗的主要障碍 ,有望成为提高中医治疗中风急性期疗效的关键 相似文献
9.
取正常成人心脏瓣膜36个,置于低浓度广谱抗生素的营养液(RP-MI1640细胞培养液)中灭菌48h,-80℃冰箱初冻,置于液氮中长期保存。灭菌前后瓣膜细菌培养阴性率分别为94.3%和100%,解冻后经光镜、电镜检查证实瓣组织细胞结构正常,组织培养葡萄糖消耗率测定示瓣组织存活良好。临床同种心脏瓣膜原位移植3例,随访6~30个月,瓣功能良好 相似文献
10.
宣威昆明两地肺癌ras基因表达及突变的比较研究 总被引:1,自引:0,他引:1
目的 :比较ras基因在宣威、昆明两地肺癌中遗传变异的差异性 .方法 :采用免疫组化染色和PCR -SSCP -DNA直接测序技术 ,对 4 5例宣威地区肺癌和 4 5例昆明地区肺癌石蜡包埋组织标本中ras蛋白的表达及k -ras基因 12密码子突变进行检测 .结果 :5 5例 (5 5 / 90 )ras蛋白表达阳性 ,其中宣威肺癌组 31例 ,昆明肺癌组 2 4例 ,2 8例 (2 8/ 90 )检测到k -ras基因 12密码子突变 .对ras基因在两组肺癌中的表达及突变进行比较分析表明 :ras蛋白表达及k -ras基因 12密码子突变在宣威肺癌组中高于昆明肺癌组 ,但差异无统计学意义 (P >0 0 5 ) ,ras蛋白在Ⅰ期肺癌病例以及腺癌病例中的表达 ,宣威肺癌组均高于昆明肺癌组 ,差异有统计学意义 (P =0 0 4 5 ,χ2 =4 5 72 ,P =0 0 32 ) .结论 :ras基因的激活是肺癌发生过程中常见的分子生物学事件 ;宣威地区肺癌与昆明地区肺癌相比 ,ras蛋白在Ⅰ期病例以及腺癌病例中的表达存在着差异 .k -ras基因 12密码子在宣威地区肺癌中的突变与昆明地区肺癌相比无明显特异性 相似文献